Navigation Links
KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Company's ADHD Prodrug Technology
Date:8/25/2010

>-amphetamine and a ligand.  In preclinical studies, KP106 demonstrated unique abuse deterrent properties along with pharmacokinetics indicative of an attenuated amphetamine exposure as compared to Vyvanse®.  These data forecast that patients receiving KP106 may experience decreased side effects and decreased risk of abuse typically associated with stimulants.  Importantly, KemPharm is positioning KP106 to be the first ever proprietary thin film dosage form for ADHD to address compliance issues, in particular, for the pediatric patient population.  KemPharm projects the filing of a new drug application (NDA) for KP106 by the end of 2012.

About KemPharm, Inc.KemPharm, Inc. is focused on the discovery and development of new chemical entities (NCEs) to treat serious medical conditions through its proprietary and broadly applicable LAT prodrug approach.  KemPharm utilizes its LAT prodrug technology to generate improved versions of FDA-approved drugs.  Each NCE creates new composition-based intellectual property, may have a shorter development timeline and reduced development costs, and may be eligible for 505(b)(2) regulatory submission.  The Company's business strategy includes seeking strategic development partners following rapid clinical proof of concept demonstration in a Phase 1 trial.  KemPharm also plans to explore discovery stage alliances with industry leaders, leveraging its prodrug know-how and LAT technology platform.  KemPharm is developing candidates for ADHD, pain, other central nervous system disorders.  www.kempharm.com

Forward Looking Statements and InformationThis release contains forward-looking statements which are not based upon historical fact, including, without limitation, "will," "should," "expect," "anticipate," "plan," "predict," "believe," "may" and "project." Such statements, including statements relating to developments, progr
'/>"/>

SOURCE KemPharm, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. KemPharm, Inc. Receives Notice of Issuance From USPTO on Patent Protecting Companys ADHD Prodrug Technology
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 19, 2014  Advanced Medical Isotope ... company engaged primarily in the development of brachytherapy ... applications, today announced that a Life Sciences Discovery ... awarded for which AMIC is the commercialization partner.  ... (WSU) for the proposal titled "Optimized Injectable Radiogels ...
(Date:12/19/2014)... CHAPEL HILL, N.C. , Dec. 19, 2014 ... how to optimize a product,s web presence to ... critical. Brand websites, in particular, must meet the ... in regulations and culture. According ... LLC, more than half of the participating companies ...
(Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, ... SRNE ;  Sorrento), an oncology company developing new ... Inc., a privately-held immuno-oncology company developing proprietary Neukoplast ... based therapy, announced today that the companies have ... next generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3Building a Best-in-Class Pharma Global Brand Website 2Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5
... PITTSBURGH, Dec. 27, 2011 Mylan Inc. (Nasdaq: ... has received final approval from the U.S. Food and Drug ... Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base). ... ® Tablets, which are used to treat hypertension. ...
...   Losing weight and saving money: two of the ... toughest to stick with beyond mid-January. To help make achieving ... of dietary supplements and support products, is offering a few ... same time. "The New Year is all ...
Cached Medicine Technology:Mylan Launches First Generic Version of Teveten® Tablets 2Lose Weight and Save Money at the Same Time in the New Year 2Lose Weight and Save Money at the Same Time in the New Year 3Lose Weight and Save Money at the Same Time in the New Year 4
(Date:12/22/2014)... The Bob Woodruff Foundation will ... more than $5 million in programs and organizations ... families. , This includes $1.3 million in grants ... with: veteran entrepreneurship; community impact; vocational training; transportation; ... injured veterans. , “The needs of those injured ...
(Date:12/22/2014)... Naples, Florida (PRWEB) December 22, 2014 ... this holiday season, the gift of health and vitality. ... is offering its three top-selling anti-aging formulas in special ... with free rush delivery. , Each bottle contains ... digestion, areas that don't work as well as we ...
(Date:12/22/2014)... 2014 Xarelto Lawsuit News : ... judges has granted a request to centralize pending and ... Court, Eastern District of Louisiana. The U.S. Judicial Panel ... 12 to transfer over 50 Xarelto cases–21 lawsuits and ... Louisiana court for consolidation under U.S. District Judge Eldon ...
(Date:12/22/2014)... December 22, 2014 Christmas is days away, ... a fast and easy solution that will please: the ... be purchased from from $25 up to $350," says Kathy ... customer satisfaction and a wide array of skin care products ... and no expiration dates. , Gift delivery past shipping ...
(Date:12/22/2014)... DC (PRWEB) December 22, 2014 ... its year-long, professional development programs this month. Faculty ... which focuses on nurse educators fast-tracked for administrative ... the Leadership Development Program for Simulation Educators, featuring ... specialized area of nursing education. , Twenty ...
Breaking Medicine News(10 mins):Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3
... held medical device manufacturer focusing on minimally ... announced presentation of its clinical results of ... procedure. The MILD procedure, is ... central canal Lumbar Spinal Stenosis,(LSS). MILD ...
... Ordan to Become CEO, Board Member, MCLEAN, Va., ... ) today announced that Paul J. Klaassen, its founder ... non-executive,chairman of the board and transition from his role ... shareholders expected to take place in,November 2008. At that ...
... collective strength of biomedical research and the scientists who ... (HEI) grant from the National Institutes of Health (NIH). ... robotic electron microscope to advance cutting-edge studies of HIV/AIDS, ... $4.8 million in total funding after it matches the ...
... Occurring Electromagnetic and Biological Light Energies for Improved Hydration, Detoxification ... ... Angeles, CA (PRWEB) July 16, 2008 -- Consumers today are ... beverages and vitamin-enriched thirst quenchers, yet millions of Americans continue ...
... The American Public,Health Association (APHA) applauds the ... a Medicare bill that would improve access to ... The bill would also cancel a scheduled 10.6 ... the Medicare program., "This bill is a ...
... by Heritage Victor Valley Medical Group, VICTORVILLE, ... today announced the appointment of Dr. Rita Miranda ... Miranda will,provide inpatient physician services for any HVVMG ... Valley Community Hospital., When Dr. Rita Miranda ...
Cached Medicine News:Health News:Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico 2Health News:Sunrise Senior Living Founder and CEO to Become Chairman 2Health News:Sunrise Senior Living Founder and CEO to Become Chairman 3Health News:With $2M NIH grant, FSU becomes 1 of world's top imaging centers 2Health News:With $2M NIH grant, FSU becomes 1 of world's top imaging centers 3Health News:With $2M NIH grant, FSU becomes 1 of world's top imaging centers 4Health News:Hydra Booster Energizes Ordinary Drinking Water for Better Absorption and Optimum Hydration, Stopping Symptoms of 'Hidden' Dehydration 2Health News:Hydra Booster Energizes Ordinary Drinking Water for Better Absorption and Optimum Hydration, Stopping Symptoms of 'Hidden' Dehydration 3Health News:Hydra Booster Energizes Ordinary Drinking Water for Better Absorption and Optimum Hydration, Stopping Symptoms of 'Hidden' Dehydration 4Health News:Hydra Booster Energizes Ordinary Drinking Water for Better Absorption and Optimum Hydration, Stopping Symptoms of 'Hidden' Dehydration 5
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: